Showing results (781-790 of 837) with videos related to

Sort By:
Pageof 84
Nature Communications|August 24, 2017
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, et al.
Acta Neuropathologica|May 11, 2021
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusionsMridul Johari, Jaakko Sarparanta, Anna Vihola, et al.
Journal of Neurology|January 23, 2019
Expanding the importance of HMERF titinopathy: new mutations and clinical aspectsJohanna Palmio, Sarah Leonard-Louis, Sabrina Sacconi, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.
Open Forum Infectious Diseases|August 10, 2023
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19Philip Robinson, Sima S Toussi, Sudeepta Aggarwal, et al.
Physical Review Letters|June 4, 2008
Internal gamma decay and the superallowed branching ratio for the beta(+) emitter (38)K(m)K G Leach, C E Svensson, G C Ball, et al.
British Journal of Cancer|June 28, 2012
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancerN Zhao, M-K Ang, X-Y Yin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2019
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancerJens Huober, Eileen Holmes, José Baselga, et al.
Pageof 84